SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,136 | -13.5% | 11,200 | 0.0% | 0.05% | -20.0% |
| Q2 2023 | $295,120 | +1.3% | 11,200 | 0.0% | 0.06% | -40.9% |
| Q4 2022 | $291,312 | -3.9% | 11,200 | 0.0% | 0.11% | +48.6% |
| Q3 2022 | $303,000 | +2.0% | 11,200 | 0.0% | 0.07% | +13.8% |
| Q2 2022 | $297,000 | -53.0% | 11,200 | 0.0% | 0.06% | -47.2% |
| Q1 2022 | $632,000 | -13.3% | 11,200 | 0.0% | 0.12% | -2.4% |
| Q4 2021 | $729,000 | +15.2% | 11,200 | 0.0% | 0.13% | +9.6% |
| Q3 2021 | $633,000 | -32.6% | 11,200 | 0.0% | 0.12% | -36.8% |
| Q2 2021 | $939,000 | +19.3% | 11,200 | 0.0% | 0.18% | +9.6% |
| Q1 2021 | $787,000 | +4.7% | 11,200 | 0.0% | 0.17% | -2.9% |
| Q4 2020 | $752,000 | +14.8% | 11,200 | 0.0% | 0.17% | -3.9% |
| Q3 2020 | $655,000 | – | 11,200 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |